The main objective of the collaboratative research study, as presented by Hoifodt, Fodstad and Feistel, was to introduce EpiSep XRC™ as a quick and sensitive method to detect, isolate and characterize tumor cells present in lymph nodes, core biopsies of suspected malignancies or fine needle aspirates. Such methods may be of significant practical value in the assessment of disease stage, prognosis and possibly in determining optimal therapy. The ability to characterize the isolated tumor cells would make it possible to assess their expression of clinically relevant tumor-associated antigens and biomarkers.
